Re: A low prostate-specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer
-
Published:2023-07
Issue:
Volume:187
Page:144-146
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Ning Hao,
Wu Haihu,
Lyu Jiaju,
Wu FeiORCID
Subject
Cancer Research,Oncology
Reference8 articles.
1. A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer;Fankhauser;Eur J Cancer,2023
2. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent;Mottet;Eur Urol,2021
3. WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer;Kench;Histopathology,2022
4. A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008;Marcus;Prostate Cancer Prostatic Dis,2012
5. Prostatic ductal adenocarcinoma controlled for tumor grade, stage, and margin status does not independently influence the likelihood of biochemical recurrence in localized prostate cancer after radical prostatectomy;Kryvenko;Arch Pathol Lab Med,2022